Search
for
Sort by
Research 451–480 of 1000+
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Laser Hair Removal in Fitzpatrick Type IV to VI Patients
- Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Efficacy and safety of Cinainu in paediatric alopecia areata: an international, double-blind, randomized, placebo-controlled, phase II/III trial
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata
- 43018 Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata From 2 Randomized Clinical Trials over a Median of 1.6 years and up to 3.6 Years of Exposure
- Activated Platelet Rich Plasma versus Non-Activated Platelet Rich Plasma in the Treatment of Alopecia Areata
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor
- Hormone Treatment for the Adult Transgender Patient
- Finasteride Counseling for Male Androgenetic Alopecia Should Reflect Updated Findings on Prostate Cancer Risk
- Efficacy and safety of finasteride?
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Evaluation of the efficacy of topical metformin 10% and 20% versus topical potent steroid in the treatment of patients with alopecia areata
- Low Risk of Hypotension in Women Treated with Spironolactone for Hair Loss
- LB1159 First-in-human clinical trial evaluating AI-09, a novel long-lasting ready-to-use liquid injectable neuromodulator for the treatment of glabellar lines
- Nanofat Injection for Facial Rejuvenation
- Evaluating safety and ethical implications of androgenetic alopecia treatments: a comparison of direct-to-consumer platforms and dermatologist visits
- Tolerance and Safety Profile of Sublingual Minoxidil in the Treatment of Androgenic Alopecia
- Efficacy and safety of systemic spironolactone for acne in female patients in Sulaymaniyah teaching center of dermatology
- Tolerance and safety profile of sublingual minoxidil in the treatment of androgenic alopecia
- Editorial: Targeted immunological therapies in dermatology
- Follicular Unit Excision (FUE) Basics
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Intralesional Platelet-Rich Plasma in the Treatment of Oral Lichen Planus: Review Article
- 022 Randomized, double-blind, placebo-controlled, single-centre, phase I safety study of intradermal injections of autologous fibroblasts isolated from the non-bulbar dermal sheath of the hair follicle to treat skin aging
- Tolerance and efficacy of a new emollient barrier cream in pediatric and adult population with mild to moderate atopic dermatitis
- Safety and efficacy of a novel skin lightening agent for melasma